PapersFlow Research Brief
Biomarkers in Disease Mechanisms
Research Guide
What is Biomarkers in Disease Mechanisms?
Biomarkers in Disease Mechanisms refers to measurable indicators, such as pentraxins including PTX3, that reveal biological processes in innate immunity, inflammation, cardiovascular diseases, tissue remodeling, infection, autoimmunity, and cancer.
This field encompasses 17,861 papers focused on pentraxins like PTX3 for pattern recognition, complement interaction, and biomarker roles in disease. Research highlights PTX3's functions in innate immunity, inflammation control, and therapeutic potential across infections and cancers. Growth data over the past five years is not available.
Topic Hierarchy
Research Sub-Topics
PTX3 in Innate Immunity
This sub-topic examines the role of PTX3 as a pattern recognition molecule in the recognition of pathogens and activation of innate immune responses. Researchers investigate PTX3 interactions with microbes, complement activation, and its protective functions in infections.
PTX3 as Cardiovascular Biomarker
This area explores PTX3 as a prognostic biomarker in atherosclerosis, vascular inflammation, and heart failure. Studies focus on its correlation with endothelial dysfunction, plaque instability, and clinical outcomes in cardiovascular patients.
Pentraxins in Tissue Remodeling
Researchers study pentraxin involvement in extracellular matrix regulation, fibrosis, and wound healing processes. Key investigations include PTX3 modulation of collagen deposition and metalloproteinase activity in injured tissues.
PTX3 in Cancer Inflammation
This sub-topic covers PTX3's dual role in tumor-associated inflammation, angiogenesis suppression, and anti-metastatic effects in various cancers. Research analyzes its expression in tumor microenvironments and prognostic value.
PTX3 in Autoimmune Diseases
Studies investigate PTX3 dysregulation in systemic autoimmunity, including lupus, rheumatoid arthritis, and vasculitis. Focus areas include its immunomodulatory effects on complement and Fc receptor pathways.
Why It Matters
Pentraxins such as PTX3 serve as biomarkers tracking inflammation in cardiovascular diseases, with endothelial dysfunction identified as a key contributor to atherosclerosis pathobiology, as shown in 'Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis' (2016) by Gimbrone and García‐Cardeña, which received 3196 citations. In obesity, inflammatory mediators like IL-6 link fat accumulation to complications, demonstrated by Ellulu et al. (2016) in 'Obesity and inflammation: the linking mechanism and the complications' with 1828 citations. IL-6 induces hepcidin synthesis causing hypoferremia during inflammation, per Nemeth et al. (2004) in their Journal of Clinical Investigation paper with 2100 citations, aiding diagnosis in infections and autoimmunity.
Reading Guide
Where to Start
'Origin and physiological roles of inflammation' by Ruslan Medzhitov (2008) provides the foundational understanding of inflammation mechanisms essential before exploring pentraxin-specific biomarkers.
Key Papers Explained
'Origin and physiological roles of inflammation' (2008) by Medzhitov (6151 citations) establishes core inflammation principles, extended by 'Inflammatory responses and inflammation-associated diseases in organs' (2017) by Chen et al. (4741 citations) to organ-specific effects. 'Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis' (2016) by Gimbrone and García‐Cardeña (3196 citations) applies this to vascular disease, while 'Atherosclerosis is an inflammatory disease' (1999) by Ross (1444 citations) confirms inflammation's centrality. Nemeth et al. (2004) links IL-6 to iron regulation in inflammation.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Research centers on pentraxin functions in innate immunity, pattern recognition, and biomarker potential for cancer and autoimmunity, with no recent preprints or news in the last 6-12 months indicating steady focus on established mechanisms.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Origin and physiological roles of inflammation | 2008 | Nature | 6.2K | ✕ |
| 2 | Inflammatory responses and inflammation-associated diseases in... | 2017 | Oncotarget | 4.7K | ✓ |
| 3 | Endothelial Cell Dysfunction and the Pathobiology of Atheroscl... | 2016 | Circulation Research | 3.2K | ✓ |
| 4 | A small-molecule inhibitor of the NLRP3 inflammasome for the t... | 2015 | Nature Medicine | 2.6K | ✓ |
| 5 | IL-6 mediates hypoferremia of inflammation by inducing the syn... | 2004 | Journal of Clinical In... | 2.1K | ✓ |
| 6 | Obesity and inflammation: the linking mechanism and the compli... | 2016 | Archives of Medical Sc... | 1.8K | ✓ |
| 7 | Atherosclerosis is an inflammatory disease | 1999 | American Heart Journal | 1.4K | ✕ |
| 8 | The Vascular Endothelium and Human Diseases | 2013 | International Journal ... | 1.4K | ✓ |
| 9 | Cellular and molecular mechanisms of renal fibrosis | 2011 | Nature Reviews Nephrology | 1.4K | ✕ |
| 10 | Worldwide Increasing Incidence of Thyroid Cancer: Update on Ep... | 2013 | Journal of Cancer Epid... | 1.3K | ✓ |
Frequently Asked Questions
What role do pentraxins play in innate immunity?
Pentraxins like PTX3 function in pattern recognition and interaction with the complement system during innate immune responses. They contribute to inflammation control and pathogen clearance in infections. This positions them as potential biomarkers for immune-related diseases.
How does inflammation contribute to atherosclerosis?
Atherosclerosis develops as an inflammatory disease, with endothelial cell dysfunction in arterial lesion-prone areas driving pathobiology. 'Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis' (2016) by Gimbrone and García‐Cardeña details nonadaptive endothelial alterations. 'Atherosclerosis is an inflammatory disease' (1999) by Ross reinforces this mechanism.
What is the link between IL-6 and inflammation-induced hypoferremia?
IL-6 induces hepcidin synthesis in the liver, leading to hypoferremia as a response to systemic infections or inflammation. Nemeth et al. (2004) showed this in mouse models requires hepcidin regulation. The process limits iron availability to pathogens.
How does obesity drive inflammation?
Obesity triggers adipose tissue release of inflammatory mediators like TNF-α and IL-6 due to excess macronutrients. 'Obesity and inflammation: the linking mechanism and the complications' (2016) by Ellulu et al. links this to health complications. Reduced anti-inflammatory adiponectin worsens the response.
What are key organs affected by inflammatory responses?
Inflammatory responses impact the heart, pancreas, liver, kidney, lung, brain, and intestinal tract from pathogens or damaged cells. 'Inflammatory responses and inflammation-associated diseases in organs' (2017) by Chen et al. covers acute and chronic effects. These lead to organ-specific diseases.
What is the current state of research on biomarkers in disease mechanisms?
The field includes 17,861 papers on pentraxins like PTX3 in immunity and disease. Focus areas span cardiovascular disease, cancer, and autoimmunity with biomarker and therapeutic implications. No recent preprints or news coverage from the last 12 months is available.
Open Research Questions
- ? How do pentraxins like PTX3 specifically interact with the complement system to modulate inflammation in cardiovascular diseases?
- ? What mechanisms link obesity-induced IL-6 and hepcidin to complications in autoimmunity and infection?
- ? Can inhibitors of NLRP3 inflammasomes, as in Coll et al. (2015), target pentraxin-related pathways in tissue remodeling?
- ? What drives the role of endothelial dysfunction in atherosclerosis progression beyond inflammation?
- ? How do organ-specific inflammatory responses, per Chen et al. (2017), inform biomarker development for renal fibrosis?
Recent Trends
The field maintains 17,861 papers with no specified 5-year growth rate.
Top-cited works like Medzhitov at 6151 citations and Chen et al. (2017) at 4741 citations dominate, emphasizing pentraxins in inflammation and organ diseases.
2008No recent preprints or news coverage alters these trends.
Research Biomarkers in Disease Mechanisms with AI
PapersFlow provides specialized AI tools for Immunology and Microbiology researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Biomarkers in Disease Mechanisms with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Immunology and Microbiology researchers